Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
09/2010
09/02/2010US20100221222 Interferons, uses and compositions related thereto
09/02/2010US20100221219 Compositions for treating multiple sclerosis
09/02/2010US20100221210 Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
09/02/2010US20100221195 Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
09/02/2010US20100221186 Biomarkers for cardiovascular side-effects induced by cox-2 inhibitory compounds
09/02/2010US20100221185 Vaccines and vaccine components for inhibition of microbial cells
09/02/2010US20100221179 IL-1 Binding Proteins
09/02/2010US20100221178 Method for Treating the TH2-Mediated Disease
09/02/2010CA2772648A1 Antibodies specifically directed to the soluble form of ctla-4
09/02/2010CA2753337A1 Pyrazole derivatives used as ccr4 receptor antagonists
09/02/2010CA2753304A1 Tricyclic pyrazolopyrimidine derivatives as hsp inhibitors
09/02/2010CA2752003A1 Ceramide-analogous metabolites
09/01/2010EP2223922A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
09/01/2010EP2223920A2 Substituted azabicyclic compounds
09/01/2010EP2223697A1 Lactic acid bacterium-containing preparation
09/01/2010EP2223691A1 Immunemodulating oligosaccharides
09/01/2010EP2222710A1 Recombinant rsv antigens
09/01/2010EP2222706A1 Antibodies against human nkg2d and uses thereof
09/01/2010EP2222674A1 Amino triazoles as pi3k inhibitors
09/01/2010EP2222671A1 Oxadiazole derivatives active on sphingosine-1-phosphate (sip)
09/01/2010EP2222670A1 Oxadiazole derivatives for use as s1p1 agonists in the treatment of autoimmune and inflammatory disorders
09/01/2010EP2222669A1 Oxadiazole derivatives active on sphingosine-1-phosphate (sip)
09/01/2010EP2222668A1 Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
09/01/2010EP2222667A2 Novel thiophene derivatives as agonists of s1p1/edg1
09/01/2010EP1983987B1 Dihydrodiazepines useful as inhibitors of protein kinases
09/01/2010EP1430027B1 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives
09/01/2010EP1423406B1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/01/2010EP1207905B1 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
09/01/2010CN1938018B Use of compounds for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced igf-1 serum level
09/01/2010CN101821392A RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles
09/01/2010CN101821274A Bis(trimethylsilyl)phenyl compound or salt thereof, and use thereof
09/01/2010CN101820913A Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor
09/01/2010CN101817813A Crystal IV of 3-(substituted dihydroisoindolinone-2-yl)-2,6-piperidinediketone and medicinal composite thereof
09/01/2010CN101817746A Phenolic acid compound and use thereof in the preparation of anticomplementary medicaments
09/01/2010CN101816789A Lyophilized viper antivenin and preparation method thereof
09/01/2010CN101816787A An allergen dosage form
09/01/2010CN101816740A Chinese medicament formula for health insoles
09/01/2010CN101816739A Chinese medicinal composition and preparation method thereof
09/01/2010CN101816701A Process for preparing kudzu root extract instant grains
09/01/2010CN101816694A Echinacea purpurea oral liquid and preparation method and application thereof
09/01/2010CN101816693A Echinacea purpurea extract powder and preparation method and application thereof
09/01/2010CN101816692A Extraction method of chrysanthemum saponin
09/01/2010CN101816689A Processing method of ginseng
09/01/2010CN101816670A New medical application of beta-sodium aescinate
09/01/2010CN101816668A Medical application of 2-O-alpha-L-rhamnose-4,6,4'-trihydroxybenzophenone
09/01/2010CN101816665A Immunosuppressive medicament
09/01/2010CN101816652A Medicinal use and preparation of compound
09/01/2010CN101816626A Pharmaceutical compositions and dosage forms of thalidomide
09/01/2010CN101816415A Nutrition-balancing and immunity-enhancing natural green algae tablets and production method thereof
09/01/2010CN101297672B Method for producing active peptides from enzymolysis of fish proteins using active enzymes in angleworm intestinal canal
08/2010
08/31/2010US7786257 Lymphocyte receptors peptide for use as tool in prevention and treatment of infection, autoimmune and cell proliferative disorders; mimetics
08/31/2010US7786177 Phenylalanine enamide derivatives
08/31/2010US7786135 Substituted pyrroline kinase inhibitors
08/31/2010US7786123 Indolylmaleimide derivatives
08/31/2010US7786096 Inhibition of antigen presentation with poorly catabolized polymers
08/31/2010US7786048 Condensed heterocyclic pyrazole derivatives as kinase inhibitors
08/31/2010US7785838 Variants of mammalian prolactin, prolactin receptor antagonists, and methods of use
08/31/2010US7785835 A protein complex which includes a growth factor, growth factor binding protein and vitronectin; for treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring
08/31/2010US7785833 Methods and means for producing proteins with predetermined post-translational modifications
08/31/2010US7785819 Diagnosis of autoimmune disease; generate solid support, incubate with fluid sample, detect preferential antigens, compare to control, evaluate for autoimmune diseases
08/31/2010US7785804 Mammalian CX3C chemokine antibodies
08/31/2010US7785791 Polypeptide variants with altered effector function
08/31/2010US7785602 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus
08/31/2010US7785599 Albumin fusion proteins
08/31/2010CA2447779C Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
08/31/2010CA2332817C Il-6 antagonist peptides
08/31/2010CA2217871C Altered polypeptides with increased half-life
08/26/2010WO2010096418A2 Antibody molecules having specificity for human ox40
08/26/2010WO2010096385A2 Methods and compositions for the treatment of autoimmune disease
08/26/2010WO2010096170A2 Inhibition of trna synthetases and therapeutic applications thereof
08/26/2010WO2010095911A2 Composition for enhancing immunity containing plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng as an active ingredient
08/26/2010WO2010095714A1 Novel compounds and binding inhibitors, anti-allergic agents, anti-asthmatic agents and anti-inflammatory agents
08/26/2010WO2010095463A1 Immunopotentiating composition and process for producing same
08/26/2010WO2010095455A1 Hypo-immunogenic streptavidin and use thereof
08/26/2010WO2010095270A1 Anti-human α9 integrin antibody and use thereof
08/26/2010WO2010095227A1 Novel compound, and binding inhibitor, anti-allergic agent, anti-asthma agent and anti-inflammatory agent
08/26/2010WO2010095043A1 Compositions for treating an allergic or asthmatic condition
08/26/2010WO2010094986A1 Micronized carotenoid preparation as immunostimulant for crustaceans
08/26/2010WO2010094733A2 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
08/26/2010WO2010094721A1 Piperidin-pyrimidine derivatives as antagonists of histamine h4 receptor
08/26/2010WO2010094720A2 Improved anti-tnfr1 polypeptides, antibody variable domains & antagonists
08/26/2010WO2010094693A1 Glycolipid mixture with antiinflammatory acivity obtained from oscillatoria planktothrix
08/26/2010US20100218265 Immune system mediator
08/26/2010US20100216886 Polymorphs of n2-(1,1'-biphenyl-4-ylcarbonyl)-n1-[2-(4-fluorophenyl)-1,1-dimethylethyl]-l-alpha-glutamine
08/26/2010US20100216882 Aspirin-triggered lipid mediators
08/26/2010US20100216871 Use of compounds having ccr antagonism
08/26/2010US20100216838 Fexofenadine base polymorphic forms
08/26/2010US20100216823 Spirocyclic Derivatives
08/26/2010US20100216808 Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
08/26/2010US20100216801 Thiazolones for use as pi3 kinase inhibitors
08/26/2010US20100216798 Fused heterocycles as lck inhibitors
08/26/2010US20100216797 Preparation of thioarabinofuranosyl compounds and use thereof
08/26/2010US20100216785 Pharmaceutical compositions
08/26/2010US20100216781 mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
08/26/2010US20100216772 Novel Phenantridine Analogues and Uses Thereof
08/26/2010US20100216765 Kinase inhibitors
08/26/2010US20100216748 Pyrrole Derivatives and Their Methods of Use
08/26/2010US20100216724 Use of fibronectin fragment (196-203 ) as a therapeutic agent
08/26/2010US20100216722 Use of the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys as a therapeutic agent
08/26/2010US20100216716 Cell-Permeable Peptide Inhibitors Of The JNK Signal Transduction Pathway
1 ... 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 ... 1172